Andere Sprachen Samsung Biologics Co.,Ltd.

Aktien

A207940

KR7207940008

A207940

Schlusskurs Korea S.E. Andere Börsenplätze 00:00:00 22.04.2024			% 5 Tage	% 1. Jan.
802’000 ^KRW	+2.69%		+1.13%	+5.53%

08.04.	Samsung Biologics erhöht Vertragsvolumen mit MSD Schweiz	MT
20.03.	Samsung Life Science Fund investiert in Biologika-Entwickler	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Samsung Biologics Boosts Contract Size with MSD Switzerland	08.04.
Samsung Life Science Fund Invests in BrickBio	20.03.
Samsung Life Science Fund Invests in Biologics Developer	20.03.
CEO IR Newsletter : 2024 AGM Wrap Up	15.03.
Samsung Biologics : hosts 13th Annual General Meeting of Shareholders	15.03.
Samsung Group Initiates Open Hiring Drive for New Talent Acquisition	12.03.
South Korean Shares Close Higher After US Fed Chief Hints at Rate Cuts; Samsung Biologics Adds 1%	07.03.
Samsung Biologics Strikes $353 Million Deal with Belgium's UCB	07.03.
Samsung Biologics signs MOU with Seoul National University to foster bio experts	01.03.
South Korean Shares Dip on Tech, Pharma Losses; Celltrion Sheds 5% on Lackluster Q4 Earnings	29.02.
Samsung Biologics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	28.02.
Samsung Biologics awarded Leadership status by CDP for climate action efforts	14.02.
Samsung Biologics Collaborates with LegoChem Biosciences on ADC Development and Manufacturing	09.02.
Samsung Biologics partners with LegoChem Biosciences for ADC development and manufacturing	08.02.
Samsung chair found not guilty of charges connected to 2015 merger	05.02.
Samsung chief Lee Jae-yong is acquitted of financial crimes related to 2015 merger	05.02.
Samsung chief acquitted in controversial 2015 merger case	05.02.
Samsung C&T to invest in future growth and enhance shareholder value on foundation of steady performance	01.02.
Samsung Biologics's Q4 Net Income Declines	24.01.
Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating	23.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Samsung Biologics Co.,Ltd.

Aktien

A207940

KR7207940008

A207940

Andere Sprachen

Filter